Exposure to disinfection byproducts and risk of type 2 diabetes: a nested case–control study in the HUNT and Lifelines cohorts

IntroductionEnvironmental chemicals acting as metabolic disruptors have been implicated with diabetogenesis, but evidence is weak among short-lived chemicals, such as disinfection byproducts (trihalomethanes, THM composed of chloroform, TCM and brominated trihalomethanes, BrTHM).ObjectivesWe assessed whether THM were associated with type 2 diabetes (T2D) and we explored alterations in metabolic profiles due to THM exposures or T2D status.MethodsA prospective 1:1 matched case–control study (n = 430) and a cross-sectional 1:1 matched case–control study (n = 362) nested within the HUNT cohort (Norway) and the Lifelines cohort (Netherlands), respectively, were set up. Urinary biomarkers of THM exposure and mass spectrometry-based serum metabolomics were measured. Associations between THM, clinical markers, metabolites and disease status were evaluated using logistic regressions with Least Absolute Shrinkage and Selection Operator procedure.ResultsLow median THM exposures (ng/g, IQR) were measured in both cohorts (cases and controls of HUNT and Lifelines, respectively, 193 (76, 470), 208 (77, 502) and 292 (162, 595), 342 (180, 602). Neither BrTHM (OR = 0.87; 95% CI: 0.67, 1.11 | OR = 1.09; 95% CI: 0.73, 1.61), nor TCM (OR = 1.03; 95% CI: 0.88, 1.2 | OR = 1.03; 95% CI: 0.79, 1.35) were associated with incident or prevalent T2D, respectively. Metabolomics showed 48 metabolites associated with incident T2D after adjusting for sex, age and BMI, whereas a total of 244 metabolites were associated with prevalent T2D. A total of 34 metabolites were associated with the progression of T2D. In data driven logistic regression, novel biomarkers, such as cinnamoylglycine or 1-methylurate, being protective of T2D were identified. The incident T2D risk prediction model (HUNT) predicted well incident Lifelines cases (AUC = 0.845; 95% CI: 0.72, 0.97).ConclusionSuch exposome-based approaches in cohort-nested studies are warranted to better understand the environmental origins of diabetogenesis.

[1]  K. Hveem,et al.  COHORT PROFILE Cohort Profile : The HUNT Study , Norway , 2013 .

[2]  Gabi Kastenmüller,et al.  A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control , 2015, Diabetologia.

[3]  Paolo Vineis,et al.  Effects of exposure to water disinfection by-products in a swimming pool: A metabolome-wide association study , 2018, Environment international.

[4]  J. González,et al.  DNA methylation levels and long-term trihalomethane exposure in drinking water: an epigenome-wide association study , 2015, Epigenetics.

[5]  O. Franco,et al.  Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study. , 2017, International journal of epidemiology.

[6]  H. A. Barker,et al.  Amino acid degradation by anaerobic bacteria. , 1981, Annual review of biochemistry.

[7]  E. Giovannucci,et al.  Coffee, Caffeine, and Health Outcomes: An Umbrella Review. , 2017, Annual review of nutrition.

[8]  J. Idle,et al.  Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation. , 2007, Molecular endocrinology.

[9]  J. Stengård,et al.  Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland , 1992, Diabetologia.

[10]  B. Wolffenbuttel,et al.  Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study , 2017, Endocrine connections.

[11]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[12]  B. Chung,et al.  Estrogens and polyamines in breast cancer: their profiles and values in disease staging. , 1998, Cancer letters.

[13]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[14]  S. Andra,et al.  Spatial and seasonal variability of urinary trihalomethanes concentrations in urban settings. , 2014, Environmental research.

[15]  U. John,et al.  Sex differences in urine metabolites related with risk of diabetes using NMR spectroscopy: results of the study of health in pomerania , 2015, Metabolomics.

[16]  Dennis R Helsel,et al.  Fabricating data: how substituting values for nondetects can ruin results, and what can be done about it. , 2006, Chemosphere.

[17]  Jacob E. Wulff,et al.  A Novel Test for IGT Utilizing Metabolite Markers of Glucose Tolerance , 2014, Journal of diabetes science and technology.

[18]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[19]  Hugo A. Katus,et al.  A New Metabolomic Signature in Type-2 Diabetes Mellitus and Its Pathophysiology , 2014, PloS one.

[20]  Fengguo Xu,et al.  A pharmacometabonomic approach using predose serum metabolite profiles reveals differences in lipid metabolism in survival and non-survival rats treated with lipopolysaccharide , 2015, Metabolomics.

[21]  B. Wolffenbuttel,et al.  Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation , 2015, PloS one.

[22]  L. Price,et al.  Metabolites related to gut bacterial metabolism, peroxisome proliferator-activated receptor-alpha activation, and insulin sensitivity are associated with physical function in functionally-limited older adults , 2014, Aging cell.

[23]  Cheol-Young Park,et al.  1,5-Anhydroglucitol in diabetes mellitus , 2013, Endocrine.

[24]  A. Linneberg,et al.  Identification of urine metabolites associated with 5-year changes in biomarkers of glucose homoeostasis. , 2017, Diabetes & metabolism.

[25]  M. Mendez,et al.  Metabolomic characteristics of arsenic-associated diabetes in a prospective cohort in Chihuahua, Mexico. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  C. Wijmenga,et al.  Cohort Profile Cohort Profile : LifeLines , a three-generation cohort study and biobank , 2015 .

[27]  K. Makris,et al.  Time of the day dictates the variability of biomarkers of exposure to disinfection byproducts. , 2018, Environment international.

[28]  K. Midthjell,et al.  Prevalence of Thyroid Dysfunction in Autoimmune and Type 2 Diabetes: The Population-Based HUNT Study in Norway. , 2016, The Journal of clinical endocrinology and metabolism.

[29]  C. Christophi,et al.  Association between exposures to brominated trihalomethanes, hepatic injury and type II diabetes mellitus. , 2016, Environment international.

[30]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[31]  Peter Bühlmann,et al.  MissForest - non-parametric missing value imputation for mixed-type data , 2011, Bioinform..

[32]  S. Hays,et al.  Variation in urinary spot sample, 24 h samples, and longer-term average urinary concentrations of short-lived environmental chemicals: implications for exposure assessment and reverse dosimetry , 2016, Journal of Exposure Science and Environmental Epidemiology.

[33]  Jens Nielsen,et al.  Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance. , 2016, Cell metabolism.

[34]  H. Snieder,et al.  Representativeness of the LifeLines Cohort Study , 2015, PloS one.

[35]  K. Makris,et al.  Cohort-friendly protocol for a sensitive and fast method for trihalomethanes in urine using gas chromatography-Triple quadrupole mass spectrometry. , 2018, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[36]  Stephen M. Rappaport,et al.  Genetic Factors Are Not the Major Causes of Chronic Diseases , 2016, PloS one.

[37]  B. Spiegelman,et al.  International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors , 2006, Pharmacological Reviews.

[38]  D. Dockery,et al.  Coupling external with internal exposure metrics of trihalomethanes in young females from Kuwait and Cyprus , 2018, Journal of Exposure Science and Environmental Epidemiology.

[39]  Thomas Kocher,et al.  1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. , 2014, The Journal of clinical endocrinology and metabolism.

[40]  C. Matthews,et al.  Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults , 2015, Metabolomics.

[41]  Corey D. DeHaven,et al.  High Resolution Mass Spectrometry Improves Data Quantity and Quality as Compared to Unit Mass Resolution Mass Spectrometry in High- Throughput Profiling Metabolomics , 2014 .

[42]  J. Burch,et al.  Trihalomethane exposure and biomonitoring for the liver injury indicator, alanine aminotransferase, in the United States population (NHANES 1999-2006). , 2015, The Science of the total environment.

[43]  R. Garg.  Fenugreek: multiple health benefits , 2021, Nutraceuticals.

[44]  Alexander S. Banks,et al.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity , 2014, Nature.

[45]  C. Christophi,et al.  Household cleaning activities as noningestion exposure determinants of urinary trihalomethanes. , 2014, Environmental science & technology.

[46]  Florian Rohart,et al.  mixOmics: an R package for ‘omics feature selection and multiple data integration , 2017 .

[47]  T. Hankemeier,et al.  Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study , 2017, Metabolomics.

[48]  Tero Aittokallio,et al.  Early metabolic markers identify potential targets for the prevention of type 2 diabetes , 2017, Diabetologia.

[49]  Atul J. Butte,et al.  An Environment-Wide Association Study (EWAS) on Type 2 Diabetes Mellitus , 2010, PloS one.

[50]  S. Andra,et al.  Obesity-mediated association between exposure to brominated trihalomethanes and type II diabetes mellitus: an exploratory analysis. , 2014, The Science of the total environment.

[51]  S. Colagiuri,et al.  Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway , 2013, Clinical obesity.

[52]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[53]  K. Makris,et al.  Biomarkers of end of shift exposure to disinfection byproducts in nurses. , 2017, Journal of environmental sciences.

[54]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[55]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[56]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[57]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[58]  Robert Tardif,et al.  Development of Physiologically Based Toxicokinetic Models for Improving the Human Indoor Exposure Assessment to Water Contaminants: Trichloroethylene and Trihalomethanes , 2006, Journal of toxicology and environmental health. Part A.

[59]  M. Drikas,et al.  Comparison of NOM character in selected Australian and Norwegian drinking waters. , 2008, Water research.

[60]  Xiao-Juan Zhu,et al.  Health Effects from Swimming Training in Chlorinated Pools and the Corresponding Metabolic Stress Pathways , 2015, PloS one.

[61]  Dale Hattis,et al.  Genetic Polymorphism in CYP2E1: Population Distribution of CYP2E1 Activity , 2009, Journal of toxicology and environmental health. Part B, Critical reviews.

[62]  R. Sinha,et al.  Comparing metabolite profiles of habitual diet in serum and urine. , 2016, The American journal of clinical nutrition.

[63]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[64]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[65]  Augustin Scalbert,et al.  Measuring the exposome: A powerful basis for evaluating environmental exposures and cancer risk , 2013, Environmental and molecular mutagenesis.

[66]  R. F. Adams,et al.  Presence of N-acyl and acetoxy derivatives of putrescine and cadaverine in the human gut. , 1993, Gut.

[67]  W. R. Wikoff,et al.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.

[68]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[69]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[70]  Y. Hiasa,et al.  Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study , 2012, Journal of Gastroenterology.

[71]  P.W.M.H. Smeets,et al.  The Dutch secret: how to provide safe drinking water without chlorine in the Netherlands , 2009 .

[72]  M. Hanif,et al.  Fenugreek , 2023, Medicinal Plants of South Asia.

[73]  Lang Li,et al.  Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. , 2003, British journal of clinical pharmacology.

[74]  Gail Davey.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[75]  C. Wild.  Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology , 2005, Cancer Epidemiology Biomarkers & Prevention.